DSCR 6 Inhibitors
Chemical inhibitors of DSCR6 can influence its activity through various biochemical pathways by affecting the phosphorylation state of the protein itself or the proteins that interact with or regulate it. FK506 and Cyclosporin A both target the phosphatase activity of calcineurin. By forming complexes with FKBP12 and cyclophilin respectively, these compounds inhibit the dephosphorylation process that calcineurin facilitates. This inhibition maintains DSCR6 in a phosphorylated state, which reduces its activity since dephosphorylation is a crucial step for its activation. Similarly, Okadaic Acid and Calyculin A target protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, they prevent the dephosphorylation of other proteins within the signaling pathways that DSCR6 is a part of, potentially leading to a change in its functional state due to altered signaling dynamics.
Moreover, Chelerythrine and Go 6983 exert their effects by inhibiting protein kinase C (PKC). The inhibition of PKC can lead to decreased phosphorylation of proteins that are crucial in regulating DSCR6 activity. On the other hand, LY294002 and Wortmannin hinder the phosphoinositide 3-kinases (PI3K) pathway, which is instrumental in a multitude of cellular processes. Disruption of PI3K signaling can alter the activity of proteins that influence the function of DSCR6. Further along the signaling cascade, PD98059 and U0126, as MEK inhibitors, prevent the activation of the ERK pathway, which is known to regulate proteins associated with DSCR6 activity. Lastly, SB203580 and SP600125 specifically inhibit p38 MAPK and JNK, respectively. The inhibition of these kinases affects the phosphorylation state of proteins involved in the signaling pathways of DSCR6, leading to a decrease in DSCR6 activity due to modified signaling cascades. Each chemical inhibitor interacts with different molecules that are part of the regulatory network affecting DSCR6, demonstrating the complexity of cellular signaling mechanisms and their impact on protein function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506, also known as Tacrolimus, binds to FKBP12, a protein that interacts with calcineurin, forming a complex that inhibits calcineurin's phosphatase activity. DSCR6 is known to be regulated by calcineurin; therefore, inhibition of calcineurin by FK506 can lead to the reduction of DSCR6 activity by preventing its dephosphorylation and activation. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A binds to cyclophilin, and the complex formed inhibits the phosphatase activity of calcineurin. Given that DSCR6 activity is regulated by calcineurin, Cyclosporin A's inhibition of this phosphatase can lead to decreased DSCR6 activity by maintaining it in a phosphorylated, and less active, state. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). Inhibition of these phosphatases can lead to hyperphosphorylation of proteins within the same pathway as DSCR6, potentially disrupting the signaling processes that contribute to DSCR6 function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic Acid, Calyculin A is an inhibitor of protein phosphatases PP1 and PP2A. By inhibiting these enzymes, Calyculin A can lead to the hyperphosphorylation of proteins that are upstream or downstream of DSCR6, potentially inhibiting its functional activity as part of a larger signaling cascade. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a potent inhibitor of protein kinase C (PKC). Since PKC can phosphorylate proteins that interact with or regulate DSCR6, inhibition of PKC by Chelerythrine could lead to reduced phosphorylation of such proteins, thereby inhibiting DSCR6 activity. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go 6983 is a pan-PKC inhibitor that would prevent the phosphorylation of proteins that are involved in the same signaling pathways as DSCR6, potentially leading to a decrease in DSCR6 activity due to altered signaling dynamics. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of the phosphoinositide 3-kinases (PI3K). PI3K signaling is important for many cellular processes, and by inhibiting this pathway, LY294002 can alter the phosphorylation state of proteins that regulate DSCR6, thereby inhibiting its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which would similarly disrupt PI3K-dependent signaling pathways and could lead to an inhibition of DSCR6 activity through changes in the phosphorylation patterns of proteins associated with DSCR6 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is upstream of the extracellular signal-regulated kinase (ERK) pathway. The ERK pathway can regulate proteins that modulate DSCR6 activity, so inhibition by PD98059 could decrease DSCR6 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor, and its action would prevent the activation of the ERK pathway. Given that the ERK pathway can influence the function of DSCR6, inhibition by U0126 can lead to a decrease in DSCR6 activity. | ||||||